Current Diabetes Reports

, 16:117 | Cite as

Marijuana Use and Type 2 Diabetes Mellitus: a Review

Lifestyle Management to Reduce Diabetes/Cardiovascular Risk (C Shay and B Conway, Section Editors)
Part of the following topical collections:
  1. Topical Collection on Lifestyle Management to Reduce Diabetes/Cardiovascular Risk

Abstract

Marijuana is used by millions of people, with use likely to increase in the USA because of the trend towards increased decriminalization and legalization. Obesity and diabetes mellitus (DM) rates have increased dramatically in the USA over the past 30 years, with a recent estimate of 29 million individuals with DM. Because there is a plausible link between marijuana use and diabetes due to the known effects of cannabinoids on adipose tissue and glucose/insulin metabolism, it is important to study and understand how marijuana use is related to obesity and diabetes. This paper provides background on the human endocannabinoid system and studies of the association of marijuana use with body mass index/obesity, metabolic syndrome, prediabetes, and diabetes. The studies to date have shown that marijuana use is associated with either lower odds or no difference in the odds of diabetes than non-use.

Keywords

Marijuana Cannabis Diabetes Epidemiology Endocannabinoid 

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Centers for Disease Control and Prevention. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. Atlanta, GA: U.S. Department of Health and Human Services: 2014.Google Scholar
  2. 2.
    Center for Behavioral Health Statistics and Quality (CBHSQ). Behavioral Health Trends in the United States: Results from the 2014 National Survey on Drug Use and Health. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2015. HHS Publication No. SMA 15–4927, NSDUH Series H-50.Google Scholar
  3. 3.
  4. 4.
  5. 5.
    Marijuana and Health: Report of a Study by a Committee of the Institute of Medicine, Division of Health Sciences Policy. National Academy Press. Washington, D.C.1982. http://www.nap.edu/read/18942/chapter/1
  6. 6.
    Gaoni Y, Mechoulam R. Isolation, structure and partial synthesis of an active constituent of cannabis. J Am Chem Soc. 1964;86:1646–7.CrossRefGoogle Scholar
  7. 7.
    Devane WA, Dysarz FA, Johnson MR, et al. Determination and characterization of a cannabinoid receptor in the rat brain. Mol Pharmacol. 1988;34:605–13.PubMedGoogle Scholar
  8. 8.
    Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 1993;365:61–5.Google Scholar
  9. 9.
    Di Marzo V, Piscitelli F, Mechoulam R. Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes. Handb Exp Pharmacol. 2011;203:75–104. doi:10.1007/978-3-642-17214-4_4. Review.CrossRefGoogle Scholar
  10. 10.
    Lipina C, Rastedt W, Irving AJ, Hundal HS. New vistas for treatment of obesity and diabetes? Endocannabinoid signalling and metabolism in the modulation of energy balance. Bioessays. 2012;34(8):681–91. doi:10.1002/bies.201200031. Review.CrossRefPubMedGoogle Scholar
  11. 11.
    Bermudez-Silva FJ, Cardinal P, Cota D. The role of the endocannabinoid system in the neuroendocrine regulation of energy balance. J Psychopharmacol. 2012;26(1):114–24. doi:10.1177/0269881111408458. Review.CrossRefPubMedGoogle Scholar
  12. 12.
    Blüher M, Engeli S, Klöting N, Berndt J, Fasshauer M, Bátkai S, et al. Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes. 2006;55(11):3053–60.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Côté M, Matias I, Lemieux I, Petrosino S, Alméras N, Després JP, et al. Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men. Int J Obes (Lond). 2007;31(4):692–9.Google Scholar
  14. 14.
    Di Marzo V, Côté M, Matias I, Lemieux I, Arsenault BJ, Cartier A, et al. Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors. Diabetologia. 2009;52(2):213–7. doi:10.1007/s00125-008-1178-6.CrossRefPubMedGoogle Scholar
  15. 15.
    Le Strat Y, Le Foll B. Obesity and cannabis use: results from 2 representative national surveys. Am J Epidemiol. 2011;174(8):929–33. doi:10.1093/aje/kwr200.CrossRefPubMedGoogle Scholar
  16. 16.
    Smit E, Crespo CJ. Dietary intake and nutritional status of US adult marijuana users: results from the Third National Health and Nutrition Examination Survey. Public Health Nutr. 2001;4(3):781–6.CrossRefPubMedGoogle Scholar
  17. 17.
    Hayatbakhsh MR, O’Callaghan MJ, Mamun AA, Williams GM, Clavarino A, Najman JM. Cannabis use and obesity and young adults. Am J Drug Alcohol Abuse. 2010;36(6):350–6. doi:10.3109/00952990.2010.500438.CrossRefPubMedGoogle Scholar
  18. 18.
    Rodondi N, Pletcher MJ, Liu K, Hulley SB, Sidney S, Coronary Artery Risk Development in Young Adults (CARDIA) Study. Marijuana use, diet, body mass index, and cardiovascular risk factors (from the CARDIA study). Am J Cardiol. 2006;98(4):478–84.CrossRefPubMedGoogle Scholar
  19. 19.
    Warren M, Frost-Pineda K, Gold M. Body mass index and marijuana use. J Addict Dis. 2005;24(3):95–100.CrossRefPubMedGoogle Scholar
  20. 20.
    Mittleman MA, Lewis RA, Maclure M, Sherwood JB, Muller JE. Triggering myocardial infarction by marijuana. Circulation. 2001;103(23):2805–9.CrossRefPubMedGoogle Scholar
  21. 21.
    Penner EA, Buettner H, Mittleman MA. The impact of marijuana use on glucose, insulin, and insulin resistance among US adults. Am J Med. 2013;126(7):583–9. doi:10.1016/j.amjmed.2013.03.002.CrossRefPubMedGoogle Scholar
  22. 22.
    Yankey BN, Strasser S, Okosun IS. A cross-sectional analysis of the association between marijuana and cigarette smoking with metabolic syndrome among adults in the United States. Diabetes Metab Syndr. 2016;10(2 Suppl 1):S89–95. doi:10.1016/j.dsx.2016.03.001.
  23. 23.
    Vidot DC, Prado G, Hlaing WM, Florez HJ, Arheart KL, Messiah SE. Metabolic Syndrome among marijuana users in the United States: an analysis of National Health and Nutrition Examination Survey data. Am J Med. 2016;129(2):173–9. doi:10.1016/j.amjmed.2015.10.019.
  24. 24.••
    Bancks MP, Pletcher MJ, Kertesz SG, Sidney S, Rana JS, Schreiner PJ. Marijuana use and risk of prediabetes and diabetes by middle adulthood: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Diabetologia. 2015;58(12):2736–44. doi:10.1007/s00125-015-3740-3. This is the only study of the relationship of marijuana use with diabetes that has a longitudinal component and also the only one with an analysis of marijuana use and prediabetes.CrossRefPubMedGoogle Scholar
  25. 25.
    Rajavashisth TB, Shaheen M, Norris KC, Pan D, Sinha SK, Ortega J, et al. Decreased prevalence of diabetes in marijuana users: cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) III. BMJ Open. 2012;2:e000494. doi:10.1136/bmjopen-2011-000494.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.•
    Alshaarawy O, Anthony JC. Cannabis smoking and diabetes mellitus: results from meta-analysis with eight independent replication samples. Epidemiology. 2015;26(4):597–600. doi:10.1097/EDE.0000000000000314. This is the most recent published study of the relationship of marijuana use with diabetes and includes a meta-analysis of 8 separate national surveys from 2 different sources.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2007;298(22):2654–64.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Kaiser Permanente Northern California Division of ResearchOaklandUSA

Personalised recommendations